How the STEP-UP trial came to life, Â and what made the 7.2mg dose possible
What the data actually says about weight loss and side effects at higher doses
Why trial design, pharmacokinetics, and estimands matter more than you think
What’s coming next in obesity meds: duals, triples, and even antagonists
The real talk on intermittent fasting, access issues, and preaching vs. science